Skip to content

Relationship between serum vitamin K2 and osteocalcin and cross-linked C-terminal telopeptide of type I collagen in children aged 0 to 14 years

Relationship between serum vitamin K2 and osteocalcin and cross-linked C-terminal telopeptide of type I collagen in children aged 0 to 14 years

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046064
Enrollment
Unknown
Registered
2021-05-03
Start date
2021-06-01
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases related to bone metabolism in children

Interventions

0 to 1 year old group:None
Group older than 1 to 3 years old:None
Group older than 3 to 7 years old:None
Group older than 7 to 14 years old:None

Sponsors

Shenyang Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 14 Years

Inclusion criteria

Inclusion criteria: 1. Aged 0-14 years children under routine physical examination; 2. Children who meet the height and weight standards are the research objects; the reference standards for height and weight: The "Value Table of Standard Deviation Units of Height and Weight for Children and Adolescents from 0 to 18 Years Old" formulated by the Growth and Development Laboratory of Capital Institute of Pediatrics is used to calculate the height and weight of children. Weight screening; 3. The family members agree and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who have a clear cause of congenital metabolic problems and endocrine diseases are excluded, such as low phosphorus anti-D rickets, thyroid disease, diabetes, liver disease, renal insufficiency, abnormal adrenal cortex function, etc.; 2. Children suffering from severe respiratory, digestive, cardiovascular, and urinary diseases; 3. Long-term use of glucocorticoids or other drugs that affect bone metabolism (such as thiazide diuretics, heparin, bisphosphonates, oral contraceptives, aromatase inhibitors, anticonvulsants, recombinant human parathyroid hormone), etc. 4. Children who have taken vitamin K and vitamin D supplements in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Vitamin K2;Vitamin K1;vitamin D;Bone Alkalinephosphatease;Osteocalcin;N-terminal propeptide of type I procollagen;cross-linked C-terminal telopeptide of type I collagen;

Countries

China

Contacts

Public ContactDu Changxiu

Shenyang Medical College

1301770330@qq.com+86 15923518484

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026